36th Annual Meeting and Exposition
of the Controlled Release Society

July 18-22, 2009
Bella Center
Copenhagen, Denmark

Bioactive Materials Program Highlights

Biomaterials for Medicines

Nicola Tirelli, University of Manchester, U.K.

Blood Brain Barrier

Joerg Kreuter, University of Frankfurt, Germany, Nanoparticles as a Tool for Overcoming the Blood Brain Barrier

Characterization Techniques-New Approaches

Mike Reading, University of East Anglia, U.K., New Thermal and Photothermal Techniques for Pharmaceutical Materials Characterization

Gene Therapy

Chun Wang, University of Minnesota, U.S.A., Engineering Polymers for DNA Vaccine Delivery

Imaging Technologies for Diagnostics and Treatment

Zheng-Rong Lu, University of Utah, U.S.A., Contrast Enhanced MRI in Drug Development

Inhaled Medicines

Thomas Kissel, Philipps University, Germany, Nano-Carriers for Pulmonary Drug and Gene Delivery
Tamara Minko, Rutgers University, U.S.A., Inhalatory Co-delivery of Anticancer Drugs and Antisense Oligonculeotides/siRNA for Lung Cancer Treatment

Inorganic Nanoparticles

Giovanni Baldi, Colorobbia, Italy, Nano Theranostic: Magnetic Nanoparticles for Cancer Diagnosis and Therapy

Leading Edge Device Technologies

Orest Lastow, AstraZeneca, Sweden, How Should the Next Generation Inhalation Device Address the Patient Needs of the Future?
Robert Levy, Children’s Hospital of Philadelphia, U.S.A., Gene Delivery Stents: Strategies for Variable Dosing and Sustained Transgene Expression

Liposomes and Micelles

Vladimir Torchilin, Northeastern University, U.S.A., Liposomes and Polymeric Micelles as Pharmaceutical Carriers: New Horizons

Membrane Transporters–Crossing Biological Barriers

Mark Gumbleton, Cardiff University, U.K.

Nanomedicines

Hamid Ghandehari, University of Utah, U.S.A., Nanoconstructs for Controlled Delivery: Towards a Higher Degree of Definition

Nanotechnology and Animal Models: Improving Health Outcomes – an Animal Health/Veterinary and Bioactive Materials Joint Session

Patrick Couvreur, University of Paris-XI, France, Squalenoylation: A Platform for the Discovery of New Anticancer and Antiviral Nanomedicines
Jean-Christophe Leroux, University of Zurich, Switzerland, Evaluation of Gliadin/Polymer Nanocomplexes in a Mouse Model of Gluten Sensitivity

Nasal Drug Delivery

Erik Bjork, University of Uppsala, Sweden

New Candidates for Polymer Therapeutics

Paolo Ferruti, University of Milan, Italy
Etienne Schacht, University of Ghent, Belgium

New Materials for Nanotechnology

Dennis Discher, University of Pennsylvania, U.S.A.

Oral Controlled Release Technologies

Paolo Colombo, University of Parma, Italy, Drug Delivery Modules and Assemblage Technology for Combined Product Development
Abraham Rubinstein, Hebrew University of Jerusalem, Israel, Targeting GI Mucosal Diseases via the Oral Route: Design Strategies

Oral Delivery-Improving Absorption

Paul Dickinson, AstraZeneca, U.K., AstraZeneca, U.K.
Ijeoma Uchegbu, University of London, U.K., Shuttling Drug Molecules Across the Gut Ephithelium: From the Molecule to the Medicine

PEG-Based Systems: Modulating Pharmacokinetics with Polymers

Paolo Caliceti, University of Padova, Italy, PEGnology: State of the Art and Perspectives

Peptide and Protein Medicines

Simon Richardson, University of Greenwich, U.K., Copying Nature in Order to Safely Deliver Macromolecules to the Cytosol: The Use of Polymers and Recombinant Proteins

siRNA Therapy

David Rozema, Mirus Bio Corporation/University of Wisconsin, U.S.A., Dynamic PolyConjugates: A Rationally Designed, Modular Platform for Systemic siRNA Delivery

Stents

Clive Roberts, University of Nottingham, U.K.

Tissue Engineering

Ann-Christine Albertsson, University of Sweden, Sweden, Towards an Ideal Polymer Scaffold for Bone Tissue Engineering

Transdermal

Diane Burgess, University of Connecticut, U.S.A., Nanotechnology Approaches in Transdermal Drug Delivery

Tumor Targeting

Kazunori Kataoka, University of Tokyo, Japan, Smart Supramolecular Nanodevices for Tumor Targeting

Vaccines

David Putnam, Cornell University, U.S.A., Delivery of Foreign Antigens by Engineered Outer Membrane Vesicle Vaccines

All speakers, topics, and titles are subject to change.